Victoza® (Liraglutide Injection) is a prescription GLP-1 receptor agonist used in the management of type 2 diabetes mellitus and to support weight control in overweight or obese patients. It works by enhancing insulin secretion, reducing glucagon levels, slowing gastric emptying, and helping regulate appetite.

Victoza is widely prescribed worldwide due to its proven clinical efficacy, safety profile, and cardiovascular benefits in eligible patients. It is suitable for adults who require improved glycemic control alongside diet and exercise.

Available strengths include 0.6 mg, 1.2 mg, and 1.8 mg, administered once daily via a prefilled injection pen.

Medicina Overseas supplies Victoza® for international export, catering to hospitals, pharmacies, distributors, and regulated market importers. Bulk orders and long-term supply partnerships are available on enquiry.

⚠️ Prescription medicine. To be used under medical supervision only.

✅ KEY BENEFITS (OPTIONAL BUT GOOD FOR CONVERSION)

• Helps control blood sugar levels

• Supports weight management

• Once-daily injection

• Trusted global brand by Novo Nordisk

• Suitable for long-term diabetes care